Optimal Organ Protection and Blood Pressure Control with the Single Pill Combination Lisinopril, Amlodipine and Indapamide in Arterial Hypertension
Open Access
- 30 December 2020
- journal article
- research article
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 16 (6), 931-937
- https://doi.org/10.20996/1819-6446-2020-11-03
Abstract
Aim. To evaluate the single pill combination with lisinopril, amlodipine and indapamide ability in additional angioprotection achievement in patients with arterial hypertension and high pulse wave velocity (PWV) regardless on previous antihypertensive therapy (AHT). Material and methods. To the open non-randomized study duration 12 weeks 40 patients were included taking triple AHT during 6 months. All participants underwent ambulatory 24 hour blood pressure (BP) monitoring, applanation tonometry (augmentation index and central BP), pulse wave velocity assessment, laboratory tests (HbA1c, serum uric acid, high sensitive C-reactive protein [hsCRP], serum uric acid). Results. We observed additional systolic BP (SBP) and diastolic BP (DBP) reduction by 16.9% and 22.11% on lisinopril, amlodipine and indapamide single pill combination. Lisinopril, amlodipine and indapamide single pill combination decreased 24 h mean SBP by 16.77%, and 24 h mean DBP – 23.5% (ABPM data), PWV by 19.7%, augmentation index by 14.81%, central SBP by 11.9% (pConclusion. Lisinopril, amlodipine and indapamide single pill combination provided control BP, arterial elastic properties improving (augmentation index, PWV, central BP) and favorable influence on inflammation and serum uric acid level.Keywords
This publication has 27 references indexed in Scilit:
- Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for HypertensionCirculation: Cardiovascular Quality and Outcomes, 2012
- Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control studyBMJ, 2012
- Association between aldosterone induced by antihypertensive medication and arterial stiffness reduction: The J-CORE studyAtherosclerosis, 2011
- Amlodipine-Valsartan Combination Decreases Central Systolic Blood Pressure More Effectively Than the Amlodipine-Atenolol CombinationHypertension, 2010
- Differences in the Magnitude of Wave Reflection Account for Differential Effects of Amlodipine- Versus Atenolol-Based Regimens on Central Blood PressureHypertension, 2009
- Comparison of the Effects of Antihypertensive Agents on Central Blood Pressure and Arterial Stiffness in Isolated Systolic HypertensionHypertension, 2009
- Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical OutcomesJournal of the American College of Cardiology, 2006
- Benefits from angiotensin-converting enzyme inhibitor ‘beyond blood pressure lowering’: beyond blood pressure or beyond the brachial artery?Journal of Hypertension, 2005
- Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal FailureJournal of the American College of Cardiology, 2001
- Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.Journal of the American College of Cardiology, 1994